Advances in Cancer Immunotherapy (ACI) - Pittsburgh

Advances in Cancer Immunotherapy (ACI) is organized by Society for Immunotherapy of Cancer (SITC) and will be held on Dec 15, 2018 at Pittsburgh Marriott City Center, Pittsburgh, Pennsylvania, United States of America.

The target audience for this medical event is clinical oncologists, registered nurses, nurse practitioners, pharmacists, emergency physicians and the entire cancer care team. This CME Conference has been approved for a maximum of 3.75 AMA PRA Category 1 Credit(s)

Conference Description:

The Advances in Cancer Immunotherapy (ACI) programs are introductory, CME-, CPE- and CNE-accredited programs. Presented by leading and local authorities in tumor immunology and cancer immunotherapy, these 4.5 hour programs will facilitate understanding of:?

• The rationale for common approaches to immunotherapy
• The appropriate clinical management of common side effects of immunotherapy agents
• Implementing appropriate cancer immunotherapy treatments for melanoma, lung, genitourinary, head and neck, and/or hematologic cancers in clinical practice
• Overcoming operational and financial barriers to integrating cancer immunotherapy into their practice settingAppropriate implementation of cancer care counsel in the clinical setting

Conference Objectives are :

Upon completion of this program, participants will be able to:
• Describe the rationale for common approaches to cancer immunotherapy.
• Identify the appropriate clinical management of common side effects of immunotherapy agents.
• Implement cancer immunotherapy treatments for melanoma, lung, genitourinary, head and neck, and/or hematologic cancers into clinical practice appropriately.
• Identify solutions to overcome operational and financial barriers to integrating immunotherapy into their practice setting.
• Implement appropriate cancer care counsel in the clinical setting.

Additional details will be posted as soon as they are available.